Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 31 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-11-12 Abingworth LLP Former 10% Owner Conversion +126,645 $0.99 $126K 2,144,517
2019-11-12 Abingworth LLP Former 10% Owner Conversion · Series A Convertible Preferred Stock −126 2,400
2018-06-08 Abingworth LLP 10% owner Grant or award · Stock Option (Right to Buy) +12,700 12,700
2017-06-22 Abingworth LLP 10% owner Purchase · Series A Convertible Preferred Stock +2,526 $1,000.00 $2.5M 2,526
2017-06-20 Abingworth LLP 10% owner Grant or award · Stock Option (Right to Buy) +6,666 6,666
2016-06-09 Abingworth LLP 10% owner Grant or award · Stock Option (Right to Buy) +6,666 6,666

Page 1 of 1 · 6 trades